Dr. Jon Salisbury Visiting Physician Services A Member of VNA Health Group No Disclosures May 14, 2015 1:40PM – 2:00PM ©AAHCM.

Slides:



Advertisements
Similar presentations
Research By: Dr. Ritta Baena Visual Effects By: John Baena
Advertisements

Long Distance Titration of Heart Failure Medications by Telephone Calls Anne E. Steckler, RN, Heba Wassif, MD, Kalkidan Bishu, MD, Gardar Sigurdsson, MD,
Advanced Heart Failure and the Role of Mechanical Circulatory Support
Evaluation and Management of Acute Decompensated Heart Failure
Managing Chronic Heart Failure
HEART FAILURE: ANSWERS YOU NEVER GET TO QUESTIONS YOU ALWAYS ASK BART COX, M.D.FACC DIRECTOR, ADVANCED HEART FAILURE PROGRAM ASSOCIATE PROFESSOR OF MEDICINE.
Joan Stadler, RDN Robert J. Dole VAMC  The heart does not pump normally so…  Blood backs into the lungs  Fluids back into the lungs  Insufficient.
BACK TO BASICS: PHARMACOLOGY CHAD C. CRIPE, MD Department of Anesthesiology & Critical Care Medicine Division of Cardiothoracic Anesthesiology The Children’s.
Hypertension NPN 200 Medical Surgical I. Description of Hypertension Intermittent or sustained elevation in the diastolic or systolic blood pressure:
Heart Failure. Objectives Describe congestive heart failure Explain the pathophysiology of congestive heart failure Describe nursing interventions in.
Heart Failure- II prognosis And Management
Congestive heart failure guideline. Functional classification( NYHA) Class IV: symptoms at rest Class III: symptoms on less-than-ordinary exertion Class.
Heart Failure Management Focus on Primary Care Practice.
Congestive heart failure
Effects of Multidisciplinary Care of Heart Failure Patients at High Risk for Hospital Admission S. Scott Sutton, Pharm.D. Associate Clinical Professor.
HEART FAILURE “pump failure”. DEFINITION Heart failure is the inability of the heart to supply adequate blood flow and therefore oxygen delivery.
Prepared by : Nehad J. Ahmed.  Heart failure, also known as congestive heart failure (CHF), means your heart can't pump enough blood to meet your body's.
Dorset Improving Diagnosis of Heart Failure Implementation of BNP Measuring in General Practice Ist Project Steering Group 13 th Sept 2011.
Management of Chronic Heart Failure SIGN 95
Pharmacological Therapy of Heart Failure: Case presentations Steven W. Harris MHS, PA-C.
Heart Failure Karen Ruffin RN, MSN Ed..
Heart Failure and Qof Quiz Justin Walker October 2010.
Heart Failure Medicines ACE (angiotensin- converting enzyme) inhibitors ARBs (angiotensin receptor blockers) Beta-blockers Spironolactone Diuretics (water.
Drugs for CCF Heart failure is the progressive inability of the heart to supply adequate blood flow to vital organs. It is classically accompanied by significant.
JONATHAN MANT, MD; ABDALLAH AL-MOHAMMAD, MD; SHARON SWAIN, BA, PHD; AND PHILIPPE LARAMEE,DC,MSC, FOR THE GUIDELINE DEVELOPMENT GROUP CHRIS FONTIMAYOR MS-III.
Systolic CHF Therapy Rogers Kyle, MD 10/2/12. Learning Objectives Review the staging and evaluation of patients with systolic heart failure Review the.
Heart Failure Ben Starnes MD FACC Interventional Cardiology
Congestive Heart Failure
ATLAS Clinical Trial Commentary Dr Eric Topol Chairman and Professor, Department of Cardiology Director of the Joseph J Jacobs Center for Thrombosis and.
Indication:  Suspected Heart Failure With abnormal ECG or Intermediate BNP ( ) BNP:  Asymptomatic Murmur  Asymptomatic Cardiomegaly On CXR Direct.
HEART FAILURE Prevalence increasing in our ageing population Incidence doubles with each decade between 40 and 80 At any age more common in men than women.
Supporting Patients with CHF Care Transformation Collaborative of R.I. MAUREEN CLAFLIN, MSN, RN. NCM UNIVERSITY MEDICINE GOVERNOR STREET PRIMARY CARE CENTER.
Heart Failure Hazel Phillips Cardiac Support Nurse Bedford Hospital NHS Trust.
Congestive Heart Failure!!. Question 1 What’s a symptom of congestive heart failure?? A. shortness of breath B. chest pain C. No appetite D. all of the.
By Lisa Bruno Gateway Community College April 1, 2011 Instructors Ellen Cummings, RN, MSN, CNE Beth Walker, RN, MSN, CNE.
Current Management of Heart Failure GP clinical update 17 th June 2015 Dr Raj Bilku Consultant Cardiologist Clinical Lead Cardiology QEH.
Community Health Team Care Management Process PinnacleHealth Systems Don DeArmitt, M.D. Becky E. Zook RN, BSN, MS, CCP.
Background, recognition and differentials. By Dr L Axten.
Medical Progress: Heart Failure. Primary Targets of Treatment in Heart Failure. Treatment options for patients with heart failure affect the pathophysiological.
Elizabeth Johnson RN, BSN, PCCN. Upon completion of this competency the learner will:  Describe the pathophysiology of Heart Failure  Relate the differences.
To know more visit HeartFailure.com © 2015 Novartis Pharma AG, May 2015, GLCM/HTF/0028 HEART FAILURE DISEASE MANAGEMENT STANDARDS.
HEART FAILURE.
Chronic Heart Failure Clinical case scenarios for primary care Educational Resource Implementing NICE guidance August 2010 NICE clinical guideline 108.
Congestive Heart Failure ADOPTED FROM: Jarrod Eddy, PGY2 Internal Medicine Sub-I Lecture Series ADOPTED FROM: Jarrod Eddy, PGY2 Internal Medicine Sub-I.
Nursing and heart failure
TREATMENT OF HEART FAILURE From Oral Medications to Intravenous Drips Mark Puhlman MSN ANP.
Heart Failure. Background to Congestive Heart Failure Normal cardiac output needed to adequately perfuse peripheral organs – Provide O 2, nutrients, etc.
Palliative Care In Heart Failure Dr Chi-Chi Cheung Consultant in Palliative Medicine 19 th March 2015.
Heart Failure Medications Zachary Cox, PharmD Associate Professor Lipscomb University College of Pharmacy Clinical Pharmacist, Vanderbilt University Medical.
CURRENT APPROACH TO THE TREATMENT OF CONGESTIVE HEART FAILURE.
– Dr. J. Satish Kumar, MD, Department of Basic & Medical Sciences, AUST General Medicine CVS Name:________________________________________ Congestive Heart.
Internal Medicine Workshop Series Laos September /October 2009
Heart Failure: medication Types of Heart Failure Systolic (or squeezing) heart failure –Decreased pumping function of the heart, which results in fluid.
J.T. is a 62-year-old man with a history of CAD (MI 3 years ago), hypertension, depression, chronic renal insufficiency (baseline SCr is 2.8 mg/dL), peripheral.
Heart Failure J. Lynn Davis, M.D. Cardiologist CHI St. Vincent Heart Clinic Arkansas April 25, 2015.
HEART FAILURE. Excellent Care 1. Diagnosis 2. ACE-I and B blocker 3. Aldosterone antagonist 4. Exercise 5. Statin and aspirin if CVD 6. Digoxin with AF.
Chapter Chronic Heart Failure Keteyian C H A P T E R.
HF diagnosis: audit of NTproBNP uptake and outcomes across Sheffield An update on diagnosis and management of HF Dr Abdallah Al-Mohammad, MD, FRCP(Edin),
Kristina Zurita, RN Heart Failure Unit Florida Hospital 2013.
Ridha Chakeer MD PGY3. Objectives: Approximately 5.2 million Americans are affected  accounts for more than 3 million outpatient visits to primary care.
Chronic heart failure By Vishal Patel GPVTS1.
Guideline: Chronic Heart Failure
HEART FAILURE “pump failure”
Heart Failure The inability of the heart to pump sufficient blood to meet the needs of the tissues for oxygen and nutrients. A syndrome characterized.
Congestive heart failure
Section III: Neurohormonal strategies in heart failure
Section III: Neurohormonal strategies in heart failure
What is the relative risk reduction of ACEi’s/beta blockers for HFrEF?
Heart Failure through the Ages
The Heart Failure Nurse Service
Presentation transcript:

Dr. Jon Salisbury Visiting Physician Services A Member of VNA Health Group No Disclosures May 14, :40PM – 2:00PM ©AAHCM

“I haven’t sent a heart failure patient to the hospital in over 5 years” ©AAHCM

 Pathophysiologic: Inability of heart to deliver blood and oxygen  Clinical: Breathlessness and fatigue associated with cardiac disease  Associated by: Fluid retention, edema, elevated venous pressure  Clinical assessment seeks to answer to questions: ◦ Are the symptoms cardiac of non-cardiac in origin? ◦ If cardiac, what is the precise problem? ©AAHCM

Suspected Heart Failure? Dyspnea Fatigue Edema Seek evidence of heart failure 1. Clinical History2. Clinical Exam3. Investigation Dyspnea & fatigue Previous MI Angina Hypertension Valvular disease Palpitations (arrhythmia?) Smoking, alcohol abuse, family history Tachycardia Rales Raised J.V.P. Murmur Edema 3 rd heart sound EKG CXR Echocardiogram CBC, CMP, BNP Thyroid Panel

©AAHCM Etiology Systolic LV dysfunction (most common) Diastolic LV dysfunction Valvular disease Rhythm / conduction disturbance Pericardial / endocardial disease Congenital heart disease Heart Failure Confirmed

©AAHCM NYHA Class 1NYHA Class 2NYHA Class 3NYHA Class 4 No limitations of physical activity Slight limitation of physical activity. Comfortable at rest, but ordinary physical activity results in fatigue, palpitation, or dyspnea Marked limitation of physical activity. Comfortable at rest, but less than ordinary activity causes fatigue, palpitation or dyspnea Unable to perform any physical activity without discomfort – symptoms of cardiac insufficiency at rest ACE B-Blockers Hydralazine + isosorbide in African Americans Aldosterone antagonist (K+<5.0, Cr.<2.5) Loop Diuretics Loop diuretics Digoxin ARB can be used of ACE are not tolerated Consider digoxin ICD, CRT-P,+ transplantation don’t generally pertain to our patients

 ACE Inhibitors: ◦ Enalapril: 10mg BID ◦ Lisinopril: 20 – 40mg QD ◦ Captopril: 100 – 150mg daily (3 times daily dosing)  B-Blockers: ◦ Carvedilol: BID x 2 weeks, then double every 2 weeks to highest level tolerated (dizziness) to max 25mg BID ◦ Metoprolol succinate: 25mg QD (severe HF, start 12.5mg BID) ◦ Bisoprolol: 1.25mg/day, max 5mg/day  Hydralazine: 300mg/day (divided doses)  Isorbide dinitrate: 30 – 160 mg/day ©AAHCM

 Loop Diuretics: ◦ Furosemide: 20 – 80mg/day ◦ Bumetanide:.5 – 2mg/day ◦ Metolazone: 2.5 – 5mg/day (often 3X/week)  Aldosterone Antagonists: ◦ Spironolactone: 25 – 50mg/day ◦ Eplerenone: 25 – 50mg/day  Digoxin: mg/day  ARB’s ◦ Valsartan: 40mg/BID (start), 80 – 60mg/BID maintenance ◦ Candesartan: 4mg/day start, target 32/day ◦ Losartan: (not approved but beneficial) 50mg/day ©AAHCM

 Diet: weight reduction, nutritional status, Na+ intake  Fluid Intake: about 2 liters/day  Smoking: stop or reduce  Exercise: regular moderate physical activity should be encouraged  Alcohol: in moderation  Vaccinations: influenza and pneumococcal ©AAHCM

 Education, education, education!  Patient and family involvement and decision making  Assess the patient for depression and stressors  Involvement of home nursing care, PT, medications management, CHF programs  Telemonitoring ©AAHCM

 Explain clearly what heart failure is  Explain medications, how they work, dosing schedule, etc…  Explain how their disease may be just as easily be well managed at home  Reassure patient that the diagnosis of heart failure does not have to be a death sentence  Include family / caregivers in education process ©AAHCM

 Daily weights: ◦ Gain > 3lbs, take extra Lasix first, then call us!  Sliding scale of diuretics: ◦ Involve patient and family in dosing schedules  What triggers ER visits? ◦ Usually dyspnea, suggest use of pulse oximetry for reassurance ◦ Anxiety / panic: frequently will use a short acting anxiolytic ◦ Have occasionally utilized MSIR for air hunger /anxiety ◦ Treat depression  Have discussion about Palliative Care and Hospice Care ©AAHCM

 Heart failure can be well treated at home  Admission and readmissions can be significantly reduced  Follow treatment guidelines  Involve patient, family, and caregivers in decision making  Educate!  Discuss hospice / palliative with critical patients  Be reassuring that there can be life after diagnosis of heart failure! ©AAHCM